Your browser doesn't support javascript.
loading
Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis.
Tsao, Li-Chung; Crosby, Erika J; Trotter, Timothy N; Wei, Junping; Wang, Tao; Yang, Xiao; Summers, Amanda N; Lei, Gangjun; Rabiola, Christopher A; Chodosh, Lewis A; Muller, William J; Lyerly, Herbert Kim; Hartman, Zachary C.
Afiliação
  • Tsao LC; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Crosby EJ; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Trotter TN; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Wei J; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Wang T; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Yang X; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Summers AN; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Lei G; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Rabiola CA; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Chodosh LA; Department of Cancer Biology, University of Pennsylvania (UPenn), Philadelphia, Pennsylvania, USA.
  • Muller WJ; Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
  • Lyerly HK; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Hartman ZC; Department of Immunology and.
JCI Insight ; 7(6)2022 03 22.
Article em En | MEDLINE | ID: mdl-35167491

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos